| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Harrow, Inc.'s insiders have reduced their positions by a net 11,250 shares worth roughly $450K.
HROW sits in the Pharmaceuticals industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.68M | $146.05M | - | |
| CEO | 3.00M | $90.48M | - | |
| CFO | 814.7K | $24.36M | - | |
| Dir | 1.0K | $31.1K | - | |
| Dir | 1.0K | $31.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 19, 2015 | Opaleye Management Inc.60 | 10% Owner | Buy | 2,801 | $8.00 | $22,408.00 | +0.2% | |
| May 19, 2015 | Miloni Donald Paul | 10% Owner | Sell | 410,000 | $8.00 | $3,280,198.00 | -46.7% |